{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:21:05Z","timestamp":1740158465466,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s13258-021-01125-9","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T09:02:40Z","timestamp":1627117360000},"page":"1125-1135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association study between CYP20A1, CYP4F2, CYP2D6 gene polymorphisms and coronary heart disease risk in the Han population in southern China"],"prefix":"10.1007","volume":"44","author":[{"given":"Tiebiao","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8327-6501","authenticated-orcid":false,"given":"Tianbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"e0222886","DOI":"10.1371\/journal.pone.0222886","volume":"14","author":"C Andersson","year":"2019","unstructured":"Andersson C, Lyass A, Xanthakis V, Larson MG, Mitchell GF, Cheng S, Vasan RS (2019) Risk factor-based subphenotyping of heart failure in the community. PLoS ONE 14:e0222886","journal-title":"PLoS ONE"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.jacc.2016.10.039","volume":"68","author":"TL Assimes","year":"2016","unstructured":"Assimes TL, Roberts R (2016) Genetics: Implications for prevention and management of coronary artery disease. J Am Coll Cardiol 68:2797\u20132818","journal-title":"J Am Coll Cardiol"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","volume":"74","author":"PJ Connelly","year":"2019","unstructured":"Connelly PJ, Marie Freel E, Perry C, Ewan J, Touyz RM, Currie G, Delles C (2019) Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension 74:1266\u20131274","journal-title":"Hypertension"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","volume":"112","author":"RH Elbekai","year":"2006","unstructured":"Elbekai RH, El-Kadi AO (2006) Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 112:564\u2013587","journal-title":"Pharmacol Ther"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/HYPERTENSIONAHA.108.114199","volume":"52","author":"C Fava","year":"2008","unstructured":"Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, Engstr\u00f6m G, Berglund G, Minuz P, Melander O (2008) The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 52:373\u2013380","journal-title":"Hypertension"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.CIR.0000105763.51286.7F","volume":"109","author":"S Fichtlscherer","year":"2004","unstructured":"Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, Fleming I (2004) Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 109:178\u2013183","journal-title":"Circulation"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4306\/pi.2013.10.3.286","volume":"10","author":"KM Han","year":"2013","unstructured":"Han KM, Chang HS, Choi IK, Ham BJ, Lee MS (2013) CYP2D6 P34S polymorphism and outcomes of escitalopram treatment in koreans with major depression. Psychiatry Investig 10:286\u2013293","journal-title":"Psychiatry Investig"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11883-017-0641-6","volume":"19","author":"J Hartiala","year":"2017","unstructured":"Hartiala J, Schwartzman WS, Gabbay J, Ghazalpour A, Bennett BJ, Allayee H (2017) The genetic architecture of coronary artery disease: current knowledge and future opportunities. Curr Atheroscler Rep 19:6","journal-title":"Curr Atheroscler Rep"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1742-7843.2010.00657.x","volume":"108","author":"BX He","year":"2011","unstructured":"He BX, Shi L, Qiu J, Tao L, Li R, Yang L, Zhao SJ (2011) A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population. Basic Clin Pharmacol Toxicol 108:208\u2013213","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.HYP.0000151361.31736.96","volume":"45","author":"H Ho","year":"2005","unstructured":"Ho H, Pinto A, Hall SD, Flockhart DA, Li L, Skaar TC, Cadman P, O\u2019Connor DT, Wagner U, Fineberg NS et al (2005) Association between the CYP3A5 genotype and blood pressure. Hypertension 45:294\u2013298","journal-title":"Hypertension"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/FJC.0000000000000171","volume":"65","author":"S Hokimoto","year":"2015","unstructured":"Hokimoto S, Tabata N, Akasaka T, Arima Y, Kaikita K, Morita K, Kumagae N, Oniki K, Nakagawa K, Ogawa H (2015) Gender differences in impact of CYP2C19 polymorphism on development of coronary artery disease. J Cardiovasc Pharmacol 65:148\u2013152","journal-title":"J Cardiovasc Pharmacol"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"e20494","DOI":"10.1097\/MD.0000000000020494","volume":"99","author":"H Huang","year":"2020","unstructured":"Huang H, Wang Y, Wang X, Lei Y (2020) Association of CYP4F2 and CTRP9 polymorphisms and serum selenium levels with coronary artery disease. Medicine (baltimore) 99:e20494","journal-title":"Medicine (baltimore)"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0140-6736(11)60781-2","volume":"378","author":"RR Huxley","year":"2011","unstructured":"Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297\u20131305","journal-title":"Lancet"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","volume":"5","author":"M Ingelman-Sundberg","year":"2005","unstructured":"Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom J 5:6\u201313","journal-title":"Pharmacogenom J"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/heartjnl-2014-306463","volume":"102","author":"RY Khamis","year":"2016","unstructured":"Khamis RY, Ammari T, Mikhail GW (2016) Gender differences in coronary heart disease. Heart 102:1142\u20131149","journal-title":"Heart"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/5584_2016_99","volume":"956","author":"Y Kokubo","year":"2017","unstructured":"Kokubo Y, Matsumoto C (2017) Hypertension is a risk factor for several types of heart disease: review of prospective studies. Adv Exp Med Biol 956:419\u2013426","journal-title":"Adv Exp Med Biol"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11011-012-9296-8","volume":"27","author":"MJ Kotze","year":"2012","unstructured":"Kotze MJ, van Rensburg SJ (2012) Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer\u2019s disease. Metab Brain Dis 27:255\u2013266","journal-title":"Metab Brain Dis"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-020-0988-9","volume":"19","author":"T Lu","year":"2020","unstructured":"Lu T, Forgetta V, Yu OHY, Mokry L, Gregory M, Thanassoulis G, Greenwood CMT, Richards JB (2020) Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes. Cardiovasc Diabetol 19:12","journal-title":"Cardiovasc Diabetol"},{"key":"1125_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/138920008784220574","volume":"9","author":"K Lundell","year":"2008","unstructured":"Lundell K, Wikvall K (2008) Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr Drug Metab 9:323\u2013331","journal-title":"Curr Drug Metab"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.prostaglandins.2006.05.025","volume":"82","author":"M Medhora","year":"2007","unstructured":"Medhora M, Dhanasekaran A, Gruenloh SK, Dunn LK, Gabrilovich M, Falck JR, Harder DR, Jacobs ER, Pratt PF (2007) Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids. Prostaglandins Other Lipid Mediat 82:19\u201329","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1016\/j.sjbs.2020.06.022","volume":"27","author":"H Mohammed Alkreathy","year":"2020","unstructured":"Mohammed Alkreathy H, Mohammed Eid Alsayyid K, Alaama JY, Al Ghalayini K, Karim S, Esmat A, Damanhouri ZA (2020) Bisoprolol responses (PK\/PD) in hypertensive patients: a cytochrome P450 (CYP) 2D6 targeted polymorphism study. Saudi J Biol Sci 27:2727\u20132732","journal-title":"Saudi J Biol Sci"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2019.21782","volume":"323","author":"JD Mosley","year":"2020","unstructured":"Mosley JD, Gupta DK, Tan J, Yao J, Wells QS, Shaffer CM, Kundu S, Robinson-Cohen C, Psaty BM, Rich SS et al (2020) Predictive accuracy of a polygenic risk score compared with a clinical risk Score for incident coronary heart disease. JAMA 323:627\u2013635","journal-title":"JAMA"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","volume":"131","author":"AM Navar-Boggan","year":"2015","unstructured":"Navar-Boggan AM, Peterson ED, D\u2019Agostino RB Sr, Neely B, Sniderman AD, Pencina MJ (2015) Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation 131:451\u2013458","journal-title":"Circulation"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1074\/jbc.M100439200","volume":"276","author":"K Node","year":"2001","unstructured":"Node K, Ruan XL, Dai J, Yang SX, Graham L, Zeldin DC, Liao JK (2001) Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276:15983\u201315989","journal-title":"J Biol Chem"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11883-016-0628-8","volume":"18","author":"R Roberts","year":"2016","unstructured":"Roberts R (2016) Genetics-current and future role in the prevention and management of coronary artery disease. Curr Atheroscler Rep 18:78","journal-title":"Curr Atheroscler Rep"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","volume":"192","author":"P Rocic","year":"2018","unstructured":"Rocic P, Schwartzman ML (2018) 20-HETE in the regulation of vascular and cardiac function. Pharmacol Ther 192:74\u201387","journal-title":"Pharmacol Ther"},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, K\u00f6nig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C et al (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43:333\u2013338","journal-title":"Nat Genet"},{"key":"1125_CR28","first-page":"10","volume":"60","author":"A Singh","year":"2018","unstructured":"Singh A, Beniwal RP, Kukshal P, Bhatia T, Thelma BK, Deshpande SN (2018) A preliminary study of association of genetic variants with early response to olanzapine in schizophrenia. Indian J Psychiatry 60:10\u201316","journal-title":"Indian J Psychiatry"},{"key":"1125_CR29","first-page":"149","volume":"5","author":"E Sirachainan","year":"2012","unstructured":"Sirachainan E, Jaruhathai S, Trachu N, Panvichian R, Sirisinha T, Ativitavas T, Ratanatharathorn V, Chamnanphon M, Sukasem C (2012) CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients. Pharmgenom Pers Med 5:149\u2013153","journal-title":"Pharmgenom Pers Med"},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","volume":"43","author":"AA Spector","year":"2004","unstructured":"Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43:55\u201390","journal-title":"Prog Lipid Res"},{"key":"1125_CR31","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","volume":"110","author":"M Spiecker","year":"2004","unstructured":"Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, B\u00f6rgel J, M\u00fcgge A, Lindpaintner K et al (2004) Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 110:2132\u20132136","journal-title":"Circulation"},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/dna.2011.1252","volume":"31","author":"M Taspinar","year":"2012","unstructured":"Taspinar M, Aydos S, Sakiragaoglu O, Duzen IV, Yalcinkaya A, Oztuna D, Bardakci H, Tutar E, Sunguroglu A (2012) Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA Cell Biol 31:211\u2013218","journal-title":"DNA Cell Biol"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.hjc.2017.02.002","volume":"58","author":"K Toutouzas","year":"2017","unstructured":"Toutouzas K, Klettas D, Anousakis-Vlachochristou N, Melidis K, Azilazian Z, Asimomiti M, Karanasos A, Spanos A, Tsiamis E, Nihoyannopoulos P et al (2017) The -174 G>C interleukin-6 gene polymorphism is associated with angiographic progression of coronary artery disease over a 4-year period. Hell J Cardiol 58:80\u201386","journal-title":"Hell J Cardiol"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/hr.2016.23","volume":"39","author":"TC Turin","year":"2016","unstructured":"Turin TC, Okamura T, Afzal AR, Rumana N, Watanabe M, Higashiyama A, Nakao YM, Nakai M, Takegami M, Nishimura K et al (2016) Impact of hypertension on the lifetime risk of coronary heart disease. Hypertens Res 39:548\u2013551","journal-title":"Hypertens Res"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","volume":"136","author":"R Vaz-Drago","year":"2017","unstructured":"Vaz-Drago R, Cust\u00f3dio N, Carmo-Fonseca M (2017) Deep intronic mutations and human disease. Hum Genet 136:1093\u20131111","journal-title":"Hum Genet"},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1476-511X-13-83","volume":"13","author":"C Yu","year":"2014","unstructured":"Yu C, Yan Q, Fu C, Shi W, Wang H, Zeng C, Wang X (2014) CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population. Lipids Health Dis 13:83","journal-title":"Lipids Health Dis"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"34398","DOI":"10.18632\/oncotarget.16186","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lv S, Guo C, Shi C, Chi Y, Zhao L, Wang G, Wang Z (2017) Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han Population. Oncotarget 8:34398\u201334404","journal-title":"Oncotarget"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12872-018-0763-y","volume":"18","author":"T Zhang","year":"2018","unstructured":"Zhang T, Yu K, Li X (2018) Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases. BMC Cardiovasc Disord 18:29","journal-title":"BMC Cardiovasc Disord"},{"key":"1125_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1476-511X-13-145","volume":"13","author":"JG Zou","year":"2014","unstructured":"Zou JG, Ma YT, Xie X, Yang YN, Pan S, Adi D, Liu F, Chen BD (2014) The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China. Lipids Health Dis 13:145","journal-title":"Lipids Health Dis"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-021-01125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-021-01125-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-021-01125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T04:31:34Z","timestamp":1660797094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-021-01125-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s13258-021-01125-9","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"type":"print","value":"1976-9571"},{"type":"electronic","value":"2092-9293"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Tiebiao Liang, author Anshan Liang, author Xianbo Zhang, author Qi Wang, author Haiqing Wu, author Jun He and author Tianbo Jin declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted under the standard approved by the Ethics Committee of Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, and conformed to the ethical principles for medical research involving humans of the World Medical Association Declaration of Helsinki. All participants signed informed consent forms before participating in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}